Inovio Pharmaceuticals Profit Margin

Inovio Pharmaceuticals (INO) currently reports a profit margin of 129973190.93% as of June 2026. That compares with -38380665.75% in the prior-year period — up 438.6% year over year. That is above the Industrials sector average of 10.14%. Use the charts on this page to explore Inovio Pharmaceuticals's profit margin history and peer comparisons.

Inovio Pharmaceuticals's profit margin increased from -38380665.75% to 129973190.93% — a 438.6% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Inovio Pharmaceuticals's profit margin of 129973190.93% is higher than the Industrials sector average of 10.14%. That is roughly 1281523165.6% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Inovio Pharmaceuticals's current 129973190.93% should be judged against Industrials norms (sector average: 10.14%) and against INO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 129973190.93%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Industrials average is 10.14%. From there, open related valuation or income-statement pages for Inovio Pharmaceuticals, and consider following INO for alerts when major investors trade the stock.